Stada Group
Sandra Weigel has a diverse work experience, starting in 1998 as a Chemielaborant at NEAG. Sandra then moved to Wörwag R&D in 2004, where they worked as a Manager of Product Development until 2006. From 2006 to 2009, Sandra was the Head of Product Development at Woerwag R&D GmbH. Sandra then joined STADA Group in 2009 as the Head of Corporate Technology Transfer before taking on the role of Director Transfer Management/CI Coordinator Group Level from 2010 to 2016. From 2016 to 2022, Sandra worked as the Director Transfer & Product Performance at STADA Group. Currently, they hold the position of Director Strategy Projects at STADA Group, starting in April 2022.
Sandra Weigel received their Staatsexamen in Pharmazie from The University of Freiburg in 2002. Prior to that, they obtained a degree in Chemielaborant from Spitzner Arzneimittel in 1998. In terms of professional development, Sandra completed CSS Black Belt and CSS Green Belt certifications from ASQ in 2013. Sandra also attended Hult Ashridge in 2018-2019, however, no specific degree or field of study was mentioned for that period.
This person is not in the org chart
This person is not in any teams
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.